单侧脑膜炎:吸入ipratropium化物的一个意想不到的效果 - - 简要报告
Bar Levy1,2, Noa Ziv3,4, Irit Krause3,4
1Department of Pediatrics "C", Schneider Children's Medical Center of Israel, 14 Kaplan St., 4920235, Petah Tikva, Israel. barlev1@clalit.org.il.
European journal of pediatrics
|March 12, 2025
概括
婴儿的阳性单边肌痛病是由于吸入ipratropium化物引起的. 停止药物治疗解决了瞳孔扩张,突出了复杂儿科病例中药物副作用.
科学领域:
- 儿科医学 儿科医学
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 单侧脑膜炎,或瞳孔尺寸不平等与扩张,可以源于严重的疾病或催血性原因,如药物.
- 很少有报告说,吸入抗胆类药物伊普拉胺会在儿童中引起脑膜炎.
研究的目的:
- 报告一个婴儿二次吸入ipratropium化物后出现单侧肌痛病的病例.
- 强调在患有复杂病史的儿科患者中对药物副作用的认识.
主要方法:
- 一个患有早产和支气管肺形的六个月大的婴儿接受了吸入的ipratropium化物治疗支气管炎.
- 婴儿患有突然单侧性脑膜炎,眼科和CT扫描显示没有其他异常.
- 药物治疗中断,并监测瞳孔的大小.
主要成果:
- 婴儿在吸入ipratropium化物后发展出孤立的单边肌病.
- 在CT扫描中没有发现内或其他病理发现.
- 瞳孔大小在停止ipratropium化物后的24小时内正常化.
结论:
- 这一案例凸显出,通过吸入口罩的泄漏,ipratropium化物可以在婴儿中引起局部肌病.
- 在评估儿科患者单边肌病时,考虑药物副作用至关重要,特别是抗胆固醇药物.
- 及时识别和停止违规药物的代理可以导致iatrogenic mydriasis的快速解决.
相关概念视频
Antiasthma Drugs: Muscarinic Receptor Antagonists
198
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
198
Cholinergic Antagonists: Pharmacokinetics
395
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
395
Direct-Acting Cholinergic Agonists: Therapeutic Uses
663
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
663
Cholinergic Antagonists: Therapeutic Uses
699
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
699
Cholinergic Antagonists: Pharmacological Actions
751
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
751
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K


